{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:38:59Z","timestamp":1777718339726,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":394,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jacc.2017.11.041","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T14:06:58Z","timestamp":1516630018000},"page":"386-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure"],"prefix":"10.1016","volume":"71","author":[{"given":"Wouter","family":"Ouwerkerk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aeilko H.","family":"Zwinderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leong L.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biniyam","family":"Demissei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans L.","family":"Hillege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J.","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh J.","family":"Samani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozine M.","family":"ter Maaten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chim C.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pim","family":"van der Harst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Dickstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan A.","family":"Voors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.11.041_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.041_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.11.041_bib3","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.041_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.11.041_bib5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.11.041_bib6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.041_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.11.041_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.11.041_bib9","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.11.041_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.11.041_bib11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.11.041_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.041_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1388-9842(00)00141-0","article-title":"More \u201cmalignant\u201d than cancer? Five-year survival following a first admission for heart failure","volume":"3","author":"Stewart","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.11.041_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.108.812172","article-title":"Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people","volume":"119","author":"Jhund","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.041_bib15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/CIRCOUTCOMES.110.957571","article-title":"Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004)","volume":"3","author":"Stewart","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2017.11.041_bib16","first-page":"429","article-title":"Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure","volume":"2","author":"Voors","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2017.11.041_bib17","first-page":"ii5","article-title":"Contemporary management of heart failure in clinical practice","volume":"88","author":"Cleland","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2017.11.041_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey programme\u2013a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.11.041_bib19","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.ijcard.2012.06.116","article-title":"Discontinuation of beta-blockers in cardiovascular disease: UK primary care cohort study","volume":"167","author":"Kalra","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.041_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ejhf.531","article-title":"A\u00a0systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF","volume":"18","author":"Voors","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.11.041_bib21","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehx026","article-title":"Determinants and clinical outcome of uptitration of ACE inhibitors and beta-blockers in patients with heart failure: a prospective European study","volume":"38","author":"Ouwerkerk","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.11.041_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/clinchem\/45.2.199","article-title":"Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction","volume":"45","author":"Apple","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2017.11.041_bib23","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1309\/9GGNMURLJWJD88W3","article-title":"A\u00a0rapid point-of-care cardiac marker testing strategy facilitates the rapid diagnosis and management of chest pain patients in the emergency department","volume":"129","author":"Straface","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jacc.2017.11.041_bib24","first-page":"1","article-title":"mice: multivariate imputation by chained equations in R","volume":"45","author":"Buuren S van","year":"2011","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.jacc.2017.11.041_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1016\/j.jacc.2017.11.041_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cjca.2013.12.005","article-title":"A\u00a0novel approach to drug development in heart failure: toward personalized medicine","volume":"30","author":"Liu","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.041_bib27","first-page":"w14079","article-title":"Biomarker-guided personalised emergency medicine for all - hope for another hype?","volume":"145","author":"Schuetz","year":"2015","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jacc.2017.11.041_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ijcard.2016.08.271","article-title":"Risk-based evaluation of efficacy of rolofylline in\u00a0patients hospitalized with acute heart failure\u00a0-\u00a0Post-hoc analysis of the PROTECT trial","volume":"223","author":"Demissei","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.041_bib29","first-page":"429","article-title":"Factors influencing the predictive power of models for predicting mortality and\/or heart failure hospitalization in patients with heart failure","volume":"2","author":"Ouwerkerk","year":"2014","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2017.11.041_bib30","first-page":"147","article-title":"Cardiac biomarkers: new tools for heart failure management","volume":"2","author":"Iqbal","year":"2012","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.jacc.2017.11.041_bib31","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.amjcard.2008.01.047","article-title":"Relation of blood urea nitrogen to long-term mortality in patients with heart failure","volume":"101","author":"Cauthen","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.11.041_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.hfc.2014.04.005","article-title":"Novel biomarkers in heart failure with preserved ejection fraction","volume":"10","author":"Shah","year":"2014","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jacc.2017.11.041_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/CIRCHEARTFAILURE.108.770834","article-title":"Blood urea nitrogen and serum creatinine: not married in heart failure","volume":"1","author":"Schrier","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2017.11.041_bib34","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/01.CIR.0000126889.97626.B8","article-title":"High-density lipoprotein and cardiovascular risk","volume":"109","author":"Toth","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.11.041_bib35","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0735-1097(02)01854-5","article-title":"Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure","volume":"39","author":"Horwich","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.11.041_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCHEARTFAILURE.113.000242","article-title":"Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure","volume":"7","author":"van Deursen","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2017.11.041_bib37","first-page":"164","article-title":"The WAP four-disulfide core domain protein HE4: a novel biomarker for heart failure","volume":"1","author":"de Boer","year":"2013","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2017.11.041_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2288-14-116","article-title":"Validation of prediction models based on lasso regression with multiply imputed data","volume":"14","author":"Musoro","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jacc.2017.11.041_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.11.041_bib40","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0735-1097(98)00464-1","article-title":"High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril","volume":"32","author":"van Veldhuisen","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717417207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717417207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T02:49:19Z","timestamp":1656730159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717417207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0735109717417207"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.11.041","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732592228.793583483","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}